Related references
Note: Only part of the references are listed.Tebentafusp for the treatment of metastatic uveal melanoma
Timo E. Schank et al.
FUTURE ONCOLOGY (2022)
lncRNA ELFN1-AS1 predicts poor prognosis and promotes tumor progression of non-small cell lung cancer by sponging miR-497
Bin Yang et al.
CANCER BIOMARKERS (2022)
Hypoxia-Induced Upregulation of lncRNA ELFN1-AS1 Promotes Colon Cancer Growth and Metastasis Through Targeting TRIM14 via Sponging miR-191-5p
Xu Jing et al.
FRONTIERS IN PHARMACOLOGY (2022)
Computed Tomography Imaging-Based Radiogenomics Analysis Reveals Hypoxia Patterns and Immunological Characteristics in Ovarian Cancer
Songwei Feng et al.
FRONTIERS IN IMMUNOLOGY (2022)
Identification of Immunological Characteristics and Immune Subtypes Based on Single-Sample Gene Set Enrichment Analysis Algorithm in Lower-Grade Glioma
Yunyang Zhu et al.
FRONTIERS IN GENETICS (2022)
Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer
Jirong Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Genetic Landscape and Emerging Therapies in Uveal Melanoma
Rino S. Seedor et al.
CANCERS (2021)
Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis
Wende Hao et al.
JOURNAL OF OVARIAN RESEARCH (2021)
Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis
Yu-Xiao Chen et al.
FRONTIERS IN GENETICS (2021)
Identification of Six Autophagy-Related-lncRNA Prognostic Biomarkers in Uveal Melanoma
Yao Chen et al.
DISEASE MARKERS (2021)
The Genetics of Uveal Melanoma: Overview and Clinical Relevance
Aline Isabel Riechardt et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2021)
Identification and validation of tumor microenvironment-related lncRNA prognostic signature for uveal melanoma
Chen-Lu Liao et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2021)
m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
Feng Xu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
The Role of LncRNAs in Uveal Melanoma
Paula Milan-Rois et al.
CANCERS (2021)
Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
Ji Yin et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Uveal melanoma: Towards a molecular understanding
Kyra N. Smit et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2020)
Update on uveal melanoma: Translational research from biology to clinical practice (Review)
Miguel A. Ortega et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
Weifeng Hong et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer
Youkun Jie et al.
BIOENGINEERED (2020)
Uveal melanoma: physiopathology and new in situ-specific therapies
E. B. Souto et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Immunotherapies for the Treatment of Uveal Melanoma-History and Future
Timo E. Schank et al.
CANCERS (2019)
The Role of Non-coding RNAs in Oncology
Frank J. Slack et al.
CELL (2019)
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
Kalijn Fredrike Bol et al.
CANCERS (2019)
Continued Poor Survival in Metastatic Uveal Melanoma Implications for Molecular Prognostication, Surveillance Imaging, Adjuvant Therapy, and Clinical Trials
Douglas B. Johnson et al.
JAMA OPHTHALMOLOGY (2018)
Treatment of uveal melanoma: where are we now?
Jessica Yang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Clinical Outcomes in Metastatic Uveal Melanoma Treated With PD-1 and PD-L1 Antibodies
Alain P. Algazi et al.
CANCER (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?
Jerry Y. Niederkorn
FRONTIERS IN IMMUNOLOGY (2012)
Uveal Melanoma: Trends in Incidence, Treatment, and Survival
Arun D. Singh et al.
OPHTHALMOLOGY (2011)